Variation in Both IL28B and KIR2DS3 Genes Influence Pegylated Interferon and Ribavirin Hepatitis C Treatment Outcome in HIV-1 Co-Infection

• Ciara Keane ,

  Contributed equally to this work with: Ciara Keane, Daire O’Shea

  Affiliation Natural Killer Cell Group, School of Biochemistry & Immunology, Trinity College, Dublin, Ireland

  ⨯
• Daire O’Shea ,

  Contributed equally to this work with: Ciara Keane, Daire O’Shea

  Affiliation Department of GU Medicine & Infectious Diseases, St. James’s Hospital, Dublin, Ireland

  ⨯
• Thomas Reiberger,

  Affiliation Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Markus Peck-Radosavljevic,

  Affiliation Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Gillian Farrell,

  Affiliation Department of GU Medicine & Infectious Diseases, St. James’s Hospital, Dublin, Ireland

  ⨯
• Colm Bergin ,

  ¶These authors also contributed equally to this work.

  Affiliation Department of GU Medicine & Infectious Diseases, St. James’s Hospital, Dublin, Ireland

  ⨯
• Clair M. Gardiner

  * E-mail: clair.gardiner@tcd.ie

  ¶These authors also contributed equally to this work.

  Affiliation Natural Killer Cell Group, School of Biochemistry & Immunology, Trinity College, Dublin, Ireland

  ⨯